Navigation Links
Novel Enzyme Shows Potential As An Anti-HIV Target

At just 9.8 kilobases, the HIV genome pales in comparison to the 3.2 gigabases of its human and nonhuman primate targets. The compact retrovirus encodes just 14 proteins, which play different roles in promoting viral infection and virulence. As a retrovirus, HIV uses the host’s cellular machinery—including RNA polymerases, which carry out transcription—to copy its RNA genome into DNA and infiltrate human chromosomal DNA. Once the virus is integrated (now called a provirus), its genes can be transcribed.

Adept as HIV is in exploiting its host’s molecular resources, the virus can’t establish a foothold without the services of its skeleton crew. The HIV transcription factor Tat (“transactivator of transcription?, for example, is an essential regulator of HIV gene expression. Without Tat, HIV transcripts don’t reach full length and can’t effect viral replication. In a new study, Melanie Ott and colleagues identify an enzyme that regulates viral transcription by modifying Tat.

The regulation of HIV genes depends on a complex interplay between proviral DNA, cellular proteins and transcription factors, and Tat. Unlike most transcription factors, Tat activates transcription by binding to RNA, specifically to a bulging “stem-loop?structure that forms at one end of all viral transcripts called the trans-acting responsive element (TAR). Tat binding to TAR requires recruiting the enzyme cyclin-dependent kinase 9 (CDK-9) to the HIV promoter (where transcription begins). CDK-9 chemically modifies the RNA polymerase and enhances its transcribing efficiency.

The transcription process—including the labyrinthine protein–protein and protein–DNA (and in the case of Tat, protein–RNA) interactions—is highly regulated. One process that figures prominently in this regulation is acetylation, which adds an acetyl group (a molecule made of oxygen, hydrogen, and carbon) to a molecule or protein. Histone acetylation was long thought to influence transcription by regulatin
'"/>

Source:PLoS Biology


Page: 1 2 3

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Novel technology detects human DNA mutations
3. Novel antiviral technology inhibits RSV infection in mice
4. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
5. Discovery Could Lead To Novel Approaches In HIV Treatment
6. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
7. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
8. Novel gene-silencing nanoparticles shown to inhibit Ewings sarcoma
9. Novel live reporting system to track cells
10. Field of beams - Novel system uses polarized light pulses to reveal crop health
11. Novel compounds show promise as safer, more potent insecticides

Post Your Comments:
(Date:11/20/2009)... a group of University of Oklahoma researchers wer... the human genome project. Today, the OU Advance...an international effort to sequence the tomato gen...nal Science Foundation for plant genomics. , "T...o improving the tomato and crop yields will improv...
(Date:11/20/2009)...tion in the origin of biological molecules like RN... of years ago from simple precursors. Now, in a st...taly have reconstructed one of the earliest evolut...om individual subunits using nothing but warm wate...of the first biological molecules present, before ...
(Date:11/20/2009)...oduction of a single bacterial gene into yeast, re...he Netherlands achieved three improvements in bioe...: ,More ethanol, less acetate and elimination of t...ion was published in the scientific journal Appli... , Bioethanol is made by the yeast Saccharomyces...
Breaking Biology News(10 mins):NSF awards $7.5M grant to University of Oklahoma for plant genomics 2Delft breakthrough in bioethanol production from agricultural waste 2Nanyang Technological University and UK partners heightens cooperation in water industry 10235 1Nanyang Technological University and UK partners heightens cooperation in water industry 10235 2Nanyang Technological University and UK partners heightens cooperation in water industry 10235 3Study Counters Warnings on Quit Smoking Drug 58757 1Study Counters Warnings on Quit Smoking Drug 58757 2Leading Baltimore Plastic Surgeons Join Plastic Surgery Portal Network 58752 1Leading Baltimore Plastic Surgeons Join Plastic Surgery Portal Network 58752 2
...cialist II, and Linheng Li, Ph.D., Associate Inves...ely, on a new publication that clarifies how norma...er stem cells can cause the formation of tumors. ... initiate intestinal polyposis" was posted to the ...theory that cancer stem cells initiate and drive c...
... active older adults infected with HIV has unprote...researchers. A survey of 260 HIV-positive older ad...e, took Viagra and were in a relationship. , AIDs ...03. According to the Centers for Disease Control a...IV/AIDS cases in the United States by 2015 because...
...stopped in its tracks a form of blood cancer in mi...merase, thereby shortening the ends of chromosomes...t critically short, the cell commits suicide as a ... Ph.D., the Daniel Nathans chair of molecular biol...aring online this month at Cancer Cell, uncovers a...
Other Biology News:Linheng Li Lab documents the development of cancer stem cells 21/3 of sexually active older adults with HIV/AIDs has unprotected sex 2Short chromosomes put cancer cells in forced rest 2
(Date:11/20/2009)...Newswire/ -- Karolinska Development AB today,annou...ntered into a,co-investment agreement with the com...rolinska Development and used to invest in the com... medical technology companies. EIF,has agreed to i...agreement,represents EIF,s largest single investme...
(Date:11/19/2009)...ge their cell phones and other personal electronic...de by UC San Diego engineers could lead to carbon ...this. , In recent research, published in Appli...r in the UCSD Department of Mechanical and Aerospa...oefer, have found that artificially introduced def...
(Date:11/19/2009)... Spherix Incorporated (N...diabetes therapy, and a provider of technical and ..., biotechnology and pharmaceutical companies, anno... million registered direct placement to institutio...ock and warrants to purchase up to 1,104,348 addit...
(Date:11/19/2009)...19 MONITORING FORCE GmbH,announced...nserin in the,indication treatment-relevant levodo...rphan drug status designation with the European Me... is a complication of the mainstay,treatment in ad... those,affected, since it may be disabling for the...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
...y, March 10, 2008 at 8:30am, NEW YORK, March 10 ... Inc. (Nasdaq: KERX ), announced top-line results...nex (sulodexide) for the,treatment of diabetic nep...clinical trial failed to meet the primary objectiv...on of patients that achieve therapeutic success at...
...va, Inc. (Nasdaq: ANSV ) today announced that the...lication (sNDA) with the U.S. Food and Drug,Admini...to treat the pain,associated with peripheral IV in...ocaine hydrochloride monohydrate) powder intraderm... to provide local analgesia,prior to peripheral IV...
...rted, communicated in late 2007 ...tho Biotech Products, L.P.,today modified prescrib...owing guidance from the U.S. Food and Drug Adminis...hin the erythropoiesis-stimulating agent,(ESA) cla...unplanned interim analysis,of Amgen,s PREPARE stud...
Other Biology Technology:Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 2Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 3Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 4Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 2Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 3Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 4Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 2Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 3Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 4Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 5Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 6Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 7
ApopTag Fluorescein In Situ Apoptosis Detection Kit from CHEMICON
...lor staining method for labeling DNA breaks and to... cytometry. The kit contains the instructions and ... including: positive and negative control cells fo... and rinsing buffers for processing individual ste...
...s a two color staining method for labeling DNA br...lls by flow cytometry. The kit contains the instr...sis in cells including; positive and negative cont...ng, reaction, and rinsing buffers for processing i...
PowerPac HV Power Supply With Temperature Probe from Bio-Rad
Biology Products: